Concepedia

Leilei Zang

LZ

Statistics

Publications

7

Citations

234

H-Index

7

Active since

2004

Affiliations

Second Hospital of Hebei Medical University(Current)

Hebei Medical University

Leilei Zang is an author at Second Hospital of Hebei Medical University specializing in molecular oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2004–2020

7

Publications

7

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

, , +11

Quercetin alleviates hyperthyroidism‐induced liver damage via Nrf2 Signaling pathway

Pengxin Zhao, Zhigang Hu, Weiyuan Ma et al. · BioFactors · 2020 · 46 citations

, , +14

Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway

Pengxin Zhao, Weiyuan Ma, Zhigang Hu et al. · Tumor Biology · 2015 · 35 citations

, , +15

CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis

Wen‐Hao Ma, Pengxin Zhao, Leilei Zang et al. · Journal of Endocrinological Investigation · 2020 · 31 citations

, , +13

Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway

Zhigang Hu, Pengxin Zhao, Kaili Zhang et al. · Archives of Biochemistry and Biophysics · 2020 · 24 citations

, , +16

1–5 of 7